Clinical Trial Update: Effects of PTH Replacement on Bone in Hypoparathyroidism [Phase 3]

View source ↗

Summary

Phase 3 trial investigating parathyroid hormone replacement effects on bone in hypoparathyroidism; terminated with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Digeorge Syndrome
• Hypoparathyroidism

Snippet

Sponsor: National Institute of Dental and Craniofacial Research (NIDCR) | Conditions: Hypoparathyroidism, DiGeorge Syndrome | Phase 3 | Status: TERMINATED | Results posted: 2019-01-08